Liquidia LQDA
NASDAQ LQDA
$71.05 -4.28 (-5.68%)
At close: Aug 20, 2026 · 4:00 PM EDT

Liquidia (LQDA) Net Margin (2020 - 2026)

Liquidia (LQDA) posted quarterly Net Margin of 39.8% for Q1 2026, up 126951.0% year-over-year from N/an in Q1 2025, and up 151.64% quarter-over-quarter from 15.82% in Q4 2025.

Liquidia (LQDA) Net Margin (2020 - 2026) Analysis & Trends

Liquidia's Net Margin history runs 7 years deep, the most recent figure standing at 39.8% for Q1 2026.

  • In Q1 2026, Net Margin rose 126951.0% year-over-year to 39.8%; the TTM figure through Mar 2026 stood at 64.87% (up 167020.0% YoY), while the FY2025 annual figure was 185.5%, up 144819.0% from the prior year.
  • Net Margin for Q1 2026 stood at 39.8%, up from 15.82% in the prior quarter.
  • The five-year high for Net Margin was 39.8% in Q1 2026, with the low at 4103.67% in Q1 2024.
  • The 5-year median for Net Margin is 690.03% (2023), against an average of 1004.44%.
  • The sharpest annual moves came in 2024 and 2025: Net Margin tumbled 341364 bps in 2024, then soared 287396 bps in 2025.
  • Liquidia's Net Margin stood at 95.71% in 2022, then tumbled by 533 bps to 605.83% in 2023, then slumped by 118 bps to 1320.19% in 2024, then soared by 101 bps to 15.82% in 2025, then surged by 152 bps to 39.8% in 2026.
  • Business Quant data shows LQDA's Net Margin at 39.8% in Q1 2026, 15.82% in Q4 2025, and 275.86% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Haleon 43.83 Bn 42.86 Bn - -
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn -13.91%
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn 35.09%
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn 9.28%
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn 42.51%
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn -3.16%
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn 15.06%
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn 3.95%
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn - -
10 Liquidia 6.31 Bn 6.03 Bn 160.92 Mn 43.51%

Historic Data

Download Data
DateValue
Jun 30, 2026 43.51%
Mar 31, 2026 39.80%
Dec 31, 2025 15.82%
Sep 30, 2025 -275.86%
Jun 30, 2025 -1,181.31%
Mar 31, 2025 -1,229.71%
Dec 31, 2024 -1,320.19%
Sep 30, 2024 -1,690.85%
Jun 30, 2024 -2,550.48%
Mar 31, 2024 -4,103.67%
Dec 31, 2023 -605.83%
Sep 30, 2023 -847.82%
Jun 30, 2023 -1,108.02%
Mar 31, 2023 -690.03%
Dec 31, 2022 -95.71%
Sep 30, 2022 -612.16%
Jun 30, 2022 -366.31%
Mar 31, 2022 -453.15%
Dec 31, 2021 -356.86%
Sep 30, 2021 -432.21%